Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Piperacillin/tazobactam plus tigecycline vs piperacillin/tazobactam alone in febrile neutropenic cancer patients
2006-006210-14Phase 4Active
- Sponsor
- University of Perugia
- Start
- Jul 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in febrile neutropenia (FN) and Infection comparing Piperacillin/tazobactam alone with Piperacillin/tazobactam plus tigecycline (2 arms). Primary endpoints: Overall clinical and microbiological response and In vitro susceptibility of pathogens to tigecycline. Started Jul 2007; status: active.
02
Drugs
piperacillin + tazobactamtigecycline
03
Conditions
febrile neutropenia (FN)Infection
Beyond the preview
Go deeper on 2006-006210-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006210-14.